APVO (Aptevo Therapeutics) Market Valuation
The price action of Aptevo Therapeutics (APVO) reflects typical biotech dynamics, where modest sales from a single drug are offset by R&D expenses, and the market capitalization stands at 0.00. Management is strictly limiting costs, focusing on validating the efficacy of its platforms. The business's success relies on a team of leading antibody specialists developing cutting-edge cancer treatments within the field of immunotherapy.
Comprehensive metric breakdowns and analytics for aptevotherapeutics.com (APVO)
- market price and analyst price targets:
- business market valuation indicators:
- business book valuation details:
- business debt structure and liquidity details:
Total Debt to Capital Aptevo Therapeutics|APVO - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Aptevo Therapeutics Inc.|APVO - Company Aggregate Debts|Debt to Book Capitalization Ratio Aptevo Therapeutics Inc.|APVO - Company Long-Term Loans and Borrowings|Company Short-Term Debt Aptevo Therapeutics|Quick Ratio aptevotherapeutics.com
- business earnings and investment ratios data:
APVO - Net Profit|Future Profit Aptevo Therapeutics|APVO - Company Value to Net Income|Forward P/E Multiple Aptevo Therapeutics Inc.|APVO - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Aptevo Therapeutics Inc.|APVO - Operating profit before deduction of amortization|Earnings per share for the last twelve months Aptevo Therapeutics|APVO - Net earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months aptevotherapeutics.com|APVO - Earnings growth in current year|Net earnings per share growth forecast for next year Aptevo Therapeutics
- revenue and sales details:
Fundamental company analysis:APVO (Aptevo)
Aptevo Therapeutics (APVO) maintains resilience against volatility supported by a robust supply infrastructure for biopharmaceutical components. The optimization of logistics routes and the availability of reserve stocks minimize operational risks. The capitalization dynamics of the company on the GURU.Markets platform reflect the market consensus on the total business value through the product of the share price and the number of shares. This tracker allows for the monitoring of capital preservation. Entering at historical peaks risks prolonged losses.
Key competitors
Market Value argenx ARGX|BNTX (BioNTech Inc.) - Market Valuation|ABVX: Market Valuation|ADMA: Market Value|Protagonist Therapeutics (PTGX) - Market Value|Market Value immunovant.com (IMVT)|Market Value Kiniksa|Grifols SA - Market Valuation|Market Capitalization ADPT|CLDX (Celldex Corp) - Market Value|Market Capitalization AUPH (Aurinia Pharmaceuticals)|Market Capitalization biocryst.com BCRX|VERA - Market Value|Market Value DNTH (Dianthus Therapeutics Inc)|Pharvaris Corp (PHVS) - Market Value|Market Valuation AbCellera Biologics Inc.|TRML (Tourmaline Bio, Inc.) - Market Capitalization|Market Capitalization precigen.com|Market Valuation PHAR (Pharming Group)|NKTR (Nektar Therapeutics Inc) - Market Value|Market Capitalization UPB (Upstream Bio Corp)|Market Capitalization Zenas Corp (ZBIO)|IMNM - Market Value|gossamerbio.com (GOSS) - Market Valuation|KalVista Pharmaceuticals, Inc. (KALV) - Market Value|Market Valuation Septerna, Inc.|Market Valuation PVLA|Market Capitalization Savara Pharma|Market Value Rigel Pharmaceuticals (RIGL)|anaptysbio.com - Market Capitalization|Market Capitalization ATXS (Astria Therapeutics, Inc.)|enGene Holdings Inc (ENGN) - Market Value|RAPT Therapeutics - Market Capitalization|JBIO - Market Capitalization|Aclaris Therapeutics (ACRS) - Market Value|Market Valuation KYTX (kyvernatx.com)|Market Valuation TLSA|CABA (Cabaletta Bio Inc.) - Market Value|Market Capitalization VTYX|THTX - Market Value|Avalo Therapeutics, Inc - Market Valuation|eledon.com - Market Value|AGEN - Market Value|Market Value Climb Bio Inc.|ZURA (Zura Bio) - Market Valuation|aTyr Pharmaceuticals - Market Value|Market Valuation ADAG|IMA (Ikena Oncology, Inc.) - Market Value|Market Capitalization STTK|EQ (equilliumbio.com) - Market Value|Market Capitalization CNTB (Connect Biopharma Holdings Limited)|Immunic Therapeutics (IMUX) - Market Value|ATRA - Market Value|Market Value IFRX (InflaRx N.V.)|XFOR: Market Capitalization|Adicet Bio, Inc. (ACET) - Market Capitalization|Market Value Celularity Inc|INmune Bio Corporation - Market Valuation|Market Capitalization BRNS|KZR - Market Value|SAB Biotherapeutics, Inc. - Market Valuation|Market Capitalization Akari Therapeutics PLC AKTX|ENLV: Market Valuation|Q32 Bio Inc. - Market Value|GOVX: Market Capitalization|EDSA - Market Capitalization|IBIO (iBio) - Market Capitalization|Market Valuation Carisma Tx (CARM)|Market Value XTL Biopharmaceuticals, Ltd. (XTLB)|Market Capitalization boltbio.com|Market Capitalization HCWB (HCW Biologics)|Market Capitalization aimimmuno.com AIM|ADTX - Market Value|Market Valuation GRI|XRTX (XORTX) - Market Valuation|HIND (Vyome Therapeutics) - Market Value|Market Value Revelation Biosciences|Market Value indaptusrx.com INDP|Market Value Scinai Immunotherapeutics Ltd. (SCNI)|CALI: Market Valuation|Market Capitalization AFMD (Affimed N.V.)|Market Value ALLK|HOOKIPA - Market Capitalization|IGMS - Market Capitalization|iTeos Therapeutics, Inc. (ITOS) - Market Value|Ocean Biomedical Inc - Market Value|Market Value TC BioPharm (Holdings) PLC|Market Valuation Third Harmonic Bio Inc (THRD)
